Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P05412 (
c-Jun
)
11,453
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The cytochrome P450 (CYP) 2J2
arachidonic acid epoxygenase
gene was down-regulated at a pre-translational level in human hepatoma-derived HepG2 cells incubated in a hypoxic environment; under these conditions, the expression of
c-Jun
and c-Fos mRNA and protein was increased. The 5'-upstream region of the CYP2J2 gene was isolated by amplification of a 2341 bp fragment and putative regulatory elements that resembled activator protein-1 (AP-1)-like sequences were identified. From transient transfection analysis,
c-Jun
was found to strongly activate a CYP2J2 -luciferase reporter construct, but co-transfection with plasmids encoding c-Fos or c-Fos-related antigens, Fra-1 and -2, abrogated reporter activity. Using a series of deletion-reporter constructs, a
c-Jun
-responsive module was identified between bp -152 and -50 in CYP2J2 : this region contained an AP-1-like element between bp -56 and -63. The capacity of this element to interact directly with
c-Jun
, but not c-Fos, was confirmed by electromobility-shift assay analysis. Mutagenesis of the -56/-63 element abolished most, but not all, of the activation of CYP2J2 by
c-Jun
, thus implicating an additional site within the
c-Jun
-responsive region. The present results establish an important role for
c-Jun
in the control of CYP2J2 expression in liver cells. Activation of c-Fos expression by hypoxia promotes the formation of
c-Jun
/c-Fos heterodimers, which decrease the binding of
c-Jun
to the CYP2J2 upstream region, leading to gene down-regulation.
...
PMID:Role of activator protein-1 in the down-regulation of the human CYP2J2 gene in hypoxia. 1273 30